Editorial: The role of immunotherapy in melanomas

Front Oncol. 2023 Sep 28:13:1293040. doi: 10.3389/fonc.2023.1293040. eCollection 2023.

Authors

Anna Fateeva^{1

2}, Suzie Chen^{1

2

3}

Affiliations

¹ Susan Lehman Cullman Laboratory for Cancer Research, Rutgers University, Piscataway, NJ, United States.
² Graduate Program in Cellular and Molecular Pharmacology, Rutgers University, Piscataway, NJ, United States.
³ Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, United States.

No abstract available

Keywords: adverse effects; biomarkers; combinatorial treatments; immunotherapy; melanoma; toxicity.

Publication types

Editorial

Grants and funding